166 related articles for article (PubMed ID: 21318945)
21. C1q nephropathy: a case with severe atopic dermatitis.
Ekim M; Ikinciogullari A; Berberoglu M; Tulunay O; Sencer H; Ozkaya N; Reisli I; Tumer N
Pediatr Nephrol; 2002 Jul; 17(7):547-9. PubMed ID: 12172773
[TBL] [Abstract][Full Text] [Related]
22. A clinicopathological and prognostic study of 18 children with C1q nephropathy and focal segmental glomerulosclerosis: an 18-year experience from a single center.
Peng Y; Ju T; Gao C; Xia Z; Wang M; Sun X; Wang R; Li X; Wei Y; Jia L; Chen H
J Nephrol; 2023 Jul; 36(6):1615-1625. PubMed ID: 37428438
[TBL] [Abstract][Full Text] [Related]
23. Pathology, clinical presentations, and outcomes of C1q nephropathy.
Vizjak A; Ferluga D; Rozic M; Hvala A; Lindic J; Levart TK; Jurcić V; Jennette JC
J Am Soc Nephrol; 2008 Nov; 19(11):2237-44. PubMed ID: 18650484
[TBL] [Abstract][Full Text] [Related]
24. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
Opastirakul S; Chartapisak W
J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070
[TBL] [Abstract][Full Text] [Related]
25. [MCNS, which secondary developed into incidental IgA nephropathy--a case report].
Tsunehisa N; Takemura T; Inui T; Kamiya H
Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1095-9. PubMed ID: 1289609
[TBL] [Abstract][Full Text] [Related]
26. C1q deposition in the renal allograft: a report of 24 cases.
Said SM; Cornell LD; Valeri AM; Sethi S; Fidler ME; Cosio FG; Nasr SH
Mod Pathol; 2010 Aug; 23(8):1080-8. PubMed ID: 20473274
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
[TBL] [Abstract][Full Text] [Related]
28. Dramatic response to corticosteroid therapy of nephrotic syndrome associated with IgA nephropathy.
Furuse A; Hiramatsu M; Adachi N; Karashima S; Hattori S; Matsuda I
Int J Pediatr Nephrol; 1985; 6(3):205-8. PubMed ID: 4055239
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic correlation and outcome of C1q nephropathy.
Hisano S; Fukuma Y; Segawa Y; Niimi K; Kaku Y; Hatae K; Saitoh T; Takeshita M; Iwasaki H
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1637-43. PubMed ID: 18650410
[TBL] [Abstract][Full Text] [Related]
30. IgG-associated primary glomerulonephritis in children.
Yoshikawa N; Iijima K; Shimomura M; Nakamura H; Ito H
Clin Nephrol; 1994 Nov; 42(5):281-7. PubMed ID: 7851027
[TBL] [Abstract][Full Text] [Related]
31. A male patient with steroid-dependent nephrotic syndrome for 25 years and obesity-associated focal segmental glomerulosclerosis.
Motoyama O; Muto A; Ogiwara H; Mizuiri S; Kawamura S; Iitaka K
Clin Exp Nephrol; 2004 Sep; 8(3):263-5. PubMed ID: 15480905
[TBL] [Abstract][Full Text] [Related]
32. Predominant but silent C1q deposits in mesangium on transplanted kidneys - long-term observational study.
Kanai T; Akioka Y; Miura K; Hisano M; Koike J; Yamaguchi Y; Hattori M
BMC Nephrol; 2018 Apr; 19(1):82. PubMed ID: 29625558
[TBL] [Abstract][Full Text] [Related]
33. Distinguishing C1q nephropathy from lupus nephritis.
Sharman A; Furness P; Feehally J
Nephrol Dial Transplant; 2004 Jun; 19(6):1420-6. PubMed ID: 15004260
[TBL] [Abstract][Full Text] [Related]
34. [Pathological features and clinical manifestations in 313 children with nephropathy under 6].
Dang XQ; Cao Y; Yi ZW; Xu ZC; He XJ; Huang DL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):227-32. PubMed ID: 18382057
[TBL] [Abstract][Full Text] [Related]
35. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
[TBL] [Abstract][Full Text] [Related]
36. Nephrotic syndrome among children in Kano: a clinicopathological study.
Obiagwu PN; Aliyu A; Atanda AT
Niger J Clin Pract; 2014; 17(3):370-4. PubMed ID: 24714020
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
38. A single-center study of C1q nephropathy in children.
Roberti I; Baqi N; Vyas S; Kim DU
Pediatr Nephrol; 2009 Jan; 24(1):77-82. PubMed ID: 18688655
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporine in idiopathic nephrotic syndrome.
Ponticelli C
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic correlates predict the outcome in children with steroid-resistant idiopathic nephrotic syndrome treated with pulse methylprednisolone therapy.
Kirpekar R; Yorgin PD; Tune BM; Kim MK; Sibley RK
Am J Kidney Dis; 2002 Jun; 39(6):1143-52. PubMed ID: 12046024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
